PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 105 filers reported holding PASSAGE BIO INC in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $276,000 | -24.0% | 117,161 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $363,000 | -51.2% | 117,161 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $744,000 | -36.2% | 117,161 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $1,167,000 | -24.8% | 117,161 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $1,551,000 | -62.3% | 117,161 | -50.2% | 0.01% | -61.1% |
| Q1 2021 | $4,114,000 | -31.6% | 235,362 | 0.0% | 0.02% | -21.7% |
| Q4 2020 | $6,018,000 | +75.8% | 235,362 | -9.8% | 0.02% | +64.3% |
| Q3 2020 | $3,423,000 | -54.5% | 261,066 | -5.1% | 0.01% | -57.6% |
| Q2 2020 | $7,516,000 | +73.5% | 275,000 | 0.0% | 0.03% | +22.2% |
| Q1 2020 | $4,331,000 | – | 275,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $86,697,000 | 16.89% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 870,948 | $15,224,000 | 10.38% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $43,664,000 | 10.16% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $87,561,000 | 7.02% |
| Boxer Capital, LLC | 1,928,315 | $33,707,000 | 1.14% |
| Orbimed Advisors | 6,962,899 | $121,711,000 | 1.14% |
| Vivo Capital, LLC | 1,413,508 | $24,708,000 | 0.87% |
| EMERALD ADVISERS, LLC | 499,541 | $8,732,000 | 0.32% |
| Logos Global Management LP | 125,010 | $2,185,000 | 0.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 297,713 | $5,204,000 | 0.17% |